Attached to strands of DNA, they change shape, size, and chemistry to access diseased tissue, like a key fitting into a lock

Meet Deep Genomics, a privately-held company that seeks to harness the power of deep learning to transform medicine.

U of T experts suggest crystalized materials may hold wide commercial potential.